Approaches to Utilizing Bone-targeting Therapies in mBC
Pavani Chalasani, MD, MPH
Gabriel N. Hortobagyi, MD
The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Nick McAndrew, MD, MSCE
Diving into the Efficacy & Tolerability of mBC Treatment
Colleen Bohnenkamp, PharmD, BCPS, BCOP
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Vivek Subbiah, MD
Exploring the Role of Biomarkers in Lung Cancer Treatment
Jacob Sands, MD
Biagio Ricciuti, MD
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Hope S. Rugo, MD, FASCO
Recognizing the Role of Capmatinib for METex14 in NSCLC
Edward B. Garon, MD, MS
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Prof. David Cameron
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Erika Hamilton, MD
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Kevin Kalinsky MD, MS
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Nan Chen, MD
Treating Metastatic Breast Cancer: Where Are We Now?
Seema A. Khan, MD
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Maya Leiva, PharmD, BCOP
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.